The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Cytochrome P450 and Vascular Homeostasis
Abstract
Since the initial reports that renal cytochrome P450 (CYP) enzymes can metabolize arachidonic acid to substances which affect arterial tone, it has become increasingly clear that CYP enzymes expressed within the cardiovascular system play a crucial role in the modulation of vascular homeostasis. There is strong evidence suggesting that the activation of a CYP epoxygenase in endothelial cells is an essential step in nitric oxide and prostacyclin-independent vasodilatation of several vascular beds, particularly in the heart and kidney. A smooth muscle CYP ω-hydroxylase, on the other hand, generates a vasoconstrictor eicosanoid that is central to the myogenic response. Moreover, CYP epoxygenase and ω-hydroxylase products, as well as CYP-derived reactive oxygen species, are intracellular signal transduction molecules involved in several signaling cascades affecting numerous cellular processes, including vascular cell proliferation and angiogenesis. This review summarizes the vascular effects of epoxyeicosatrienoic acids and 20-hydroxyeicosatetraenoic acid, both of which are CYP-derived metabolites of arachidonic acid, endogenously generated within endothelial and vascular smooth muscle cells. Although the link between CYP expression/activity and cardiovascular disease is currently tentative, the evidence being accumulated to suggest that CYP pathways are altered in animal models of hypertension and atherosclerosis can no longer be ignored. The development of selective pharmacological tools is, however, a prerequisite for the analysis of the involvement of specific CYP isoforms in the regulation of vascular homeostasis in human subjects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The presence of these proteins in endothelial cells makes them a significant source of superoxide in the vasculature (295, 298).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [295]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cytochrome P-450: Structure, Mechanism, and Biochemistry
de Montellano, O., & Paul, R. (1986) · Medical Entomology and Zoology · Cited by 2,663
Signal Transduction through MAP Kinase Cascades
Lewis, T. S., Shapiro, P. S., & Ahn, N. G. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
On the local reactions of the arterial wall to changes of internal pressure
Bayliss, W. M. (1902) · The Journal of Physiology · doi:10.1113/jphysiol.1902.sp000911 · Cited by 1,526
Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing Factors
Campbell, W. B., Gebremedhin, D., Pratt, P. F., & Harder, D. R. (1996) · Circulation Research · doi:10.1161/01.res.78.3.415 · Cited by 1,221
Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived Eicosanoids
Node, K., Huo, Y., Ruan, X.-L., Yang, B., Spiecker, M., Ley, K. F., Zeldin, D. C., & Liao, J. K. (1999) · Science · doi:10.1126/science.285.5431.1276 · Cited by 1,218
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Fißlthaler, B., Popp, R., Kiss, L., Potente, M., Harder, D. R., Fleming, I., & Busse, R. (1999) · Nature · doi:10.1038/46816 · Cited by 911
Self-citationGuengerich, F. P. (1995) · Springer eBooks · doi:10.1007/978-1-4757-2391-5_14 · Cited by 732
Cytochrome P450 and the Individuality of Species
Nelson, D. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1352 · Cited by 598
Capdevila, J. H., Falck, J. R., & Harris, R. C. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32049-6 · Cited by 559
Wolfrum, C., Borrmann, C. M., Börchers, T., & Spener, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051619898 · Cited by 506
Research works printed but not linked: 24
- 10.1161/hyp.25.4.854 · DOI
- 10.1161/res.81.2.258 · DOI
- 10.1161/res.83.5.501 · DOI
- 10.1161/circ.103.15.1992 · DOI
- 10.1161/res.78.3.415 · DOI
- 10.1161/circ.99.24.3132 · DOI
- 10.1161/res.88.1.44 · DOI
- 10.1161/circ.94.12.3341 · DOI
- 10.1161/str.28.5.1066 · DOI
- 10.1161/res.66.3.2306810 · DOI
- 10.1161/hyp.37.3.887 · DOI
- 10.1161/hyp.29.1.320 · DOI
- 10.1161/res.83.11.1069 · DOI
- 10.1161/str.27.5.971 · DOI
- 10.1161/res.82.6.696 · DOI
- 10.1161/res.81.5.797 · DOI
- 10.1161/circ.96.10.3610 · DOI
- 10.1161/res.85.4.349 · DOI
- 10.1161/res.80.6.877 · DOI
- 10.1161/hyp.31.1.242 · DOI
- 10.1161/hyp.33.1.408 · DOI
- 10.1161/circ.100.13.1400 · DOI
- 10.1161/res.79.4.784 · DOI
- 10.1161/res.87.11.992 · DOI
Cited by
Sorted by citations
Items 201–300 of 384
Chen, L., Tang, S., Zhang, F. F., Garcia, V. G., Falck, J. R., Schwartzman, M. L., Arbab, A. S., & Guo, A. M. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00690.2018 · Cited by 24
Fang, X., Weintraub, N. L., & Spector, A. A. (2003) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(03)00002-9 · Cited by 24
Donnelly, M. K., Conley, Y. P., Crago, E. A., Ren, D., Sherwood, P. R., Balzer, J. R., & Poloyac, S. M. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.195 · Cited by 23
The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9
Visser, L. E., van Schaik, R. H. N., Danser, A. H. J., Albert Hofman, D., Witteman, J. C. M., van Duijn, C. M., Uitterlinden, A. G., Pols, H. A. P., & Stricker, B. H. C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000236335.57046.c8 · Cited by 23
Nannelli, A., Rossignolo, F., Tolando, R., Rossato, P., Pellegatti, M., Longo, V. G., & Gervasi, P. G. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0292-1 · Cited by 23
Molecular Circuits of Resolution in the Eye
Liclican, E. L., & Gronert, K. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.99 · Cited by 22
Effect of HMGCoA Reductase Inhibitors on Cytochrome P450 Expression in Endothelial Cell Line
Thiebault, C., Masson, C., Siest, G., Batt, A., & Visvikis‐Siest, S. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31803e8756 · Cited by 23
Campbell, W. B., Holmes, B. B., Falck, J. R., Capdevila, J. H., & Gauthier, K. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00516.2005 · Cited by 23
Haplotype-based case-control study of CYP4A11 gene and myocardial infarction
Fu, Z.-Y., Nakayama, T., Sato, N., Izumi, Y., Kasamaki, Y., Shindo, A., Ohta, M., Soma, M., Aoi, N., Sato, M., et al. (2012) · Hereditas · doi:10.1111/j.1601-5223.2012.02247.x · Cited by 22
Yi, X., Zhang, B., Wang, C., Liao, D., Lin, J., & Chi, L. (2015) · Gene · doi:10.1016/j.gene.2015.03.068 · Cited by 22
Cytochrome P450 expression and catalytic activity in coronary arteries and liver of cattle
Grasso, E., Longo, V. G., Coceani, F., & GIOVANNIGERVASI, P. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.11.018 · Cited by 22
Liu, M., Zhu, Q., Wu, J., Yu, X., Hu, M.-B., Xie, X., Yang, Z., Yang, J., Feng, Y., & Yue, J. (2017) · Toxicology · doi:10.1016/j.tox.2017.02.008 · Cited by 22
Makar-Aušperger, K., Krželj, K., Benčić, M. L., Aumiler, M. R., Turk, V. E., & Božina, N. (2018) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000501 · Cited by 22
Costa, T. J. D., Ceravolo, G. S., Echem, C., Hashimoto, C., Costa, B. P., Eichler, R. A. D. S., Oliveira, M. A., Jiménez‐Altayó, F., Akamine, E. H., Dantas, A. P., et al. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00490 · Cited by 23
Zhu, P., Liu, X., LaBelle, E. F., & Freedman, B. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.4981 · Cited by 22
Tunçtan, B., Yaghini, F. A., Estes, A. M., & Malik, K. U. (2005) · Nitric Oxide · doi:10.1016/j.niox.2005.09.006 · Cited by 22
Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase
Taylor, S. J., Soleymanzadeh, F., Eldrup, A. B., Farrow, N. A., Muegge, I., Kukulka, A. J., Kabcenell, A. K., & Lombaert, S. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.074 · Cited by 22
A physiogenomic approach to study the regulation of blood pressure
Westhoff, T. H., Scheid, S., Tölle, M., Kaynak, B. L., Schmidt, S. C., Zidek, W., Sperling, S., & van der Giet, M. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00077.2005 · Cited by 22
Parker, T. A., Grover, T. R., Kinsella, J. P., Falck, J. R., & Abman, S. H. (2005) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00315.2004 · Cited by 21
Evolutionary conservation analysis of human arachidonic acid metabolism pathway genes
Wei, C., Wang, M., & Wang, X. (2023) · Life Medicine · doi:10.1093/lifemedi/lnad004 · Cited by 21
Li, S., Ling-wen, Z., Feng, L., & Chen, D. (2010) · Endocrinology · doi:10.1210/en.2010-0178 · Cited by 21
Docosahexaenoic acid trials in cystic fibrosis: A review of the rationale behind the clinical trials
Biervliet, S. V., Biervliet, J. P. V., Robberecht, E., & Christophe, A. (2005) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2004.11.001 · Cited by 21
Inoue, F., Zhang, Q., Akiyoshi, T., Aramaki, O., Iwami, D., Matsumoto, K., Kitagawa, Y., Shirasugi, N., & Niimi, M. (2007) · Transplantation · doi:10.1097/01.tp.0000287641.69795.cc · Cited by 20
Kaur‐Knudsen, D., Bojesen, S. E., & Nordestgaard, B. G. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.34 · Cited by 20
Liu, X., Zhu, P., & Freedman, B. D. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00229.2005 · Cited by 20
Schanstra, J. P., Bachvarova, M., Neau, E., Bascands, J., & Bachvarov, D. R. (2007) · Kidney International · doi:10.1038/sj.ki.5002172 · Cited by 20
Yasumoto, A., Tokuoka, S. M., Kita, Y., Shimizu, T., & Yatomi, Y. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.10.014 · Cited by 19
Cardiovascular microphysiological systems (CVMPS) for safety studies – a pharma perspective
Pointon, A., Maher, J. M., Davis, M., Baker, T. K., Cichocki, J. A., Ramsden, D., Hale, C. M., Kolaja, K. L., Lévesque, P., Sura, R., et al. (2021) · Lab on a Chip · doi:10.1039/d0lc01040e · Cited by 21
Cui, P., Lee, A. C. H., Zhou, F., & Murray, M. T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00628.x · Cited by 19
Pulmonary cytochromeP-450 2J4 is reduced in a rat model of acutePseudomonaspneumonia
Yaghi, A., Bradbury, J. A., Zeldin, D. C., Mehta, S., Bend, J. R., & McCormack, D. G. (2003) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00039.2003 · Cited by 19
Gordon, G. R., Howarth, C., & MacVicar, B. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-7678-9_15 · Cited by 17
Hammoud, S. H., Omar, A. G., Eid, A. A., & El‐Mas, M. M. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.09.007 · Cited by 18
High Salt Diet Exacerbates Vascular Contraction in the Absence of Adenosine A2A Receptor
Pradhan, I., Zeldin, D. C., Ledent, C. A., Mustafa, J. S., Falck, J. R., & Nayeem, M. A. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000058 · Cited by 18
Tunçtan, B., Yaghini, F. A., Estes, A. M., & Malik, K. U. (2008) · Archives of Pharmacal Research · doi:10.1007/s12272-001-1238-x · Cited by 18
Differential gene expression in the kidney of sickle cell transgenic mice: upregulated genes
Rybicki, A. C., Fabry, M. E., Does, M. D., Kaul, D. K., & Nagel, R. L. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2003.08.002 · Cited by 18
Genetic variance in CYP2C8 and increased risk of myocardial infarction
Rodenburg, E. M., Visser, L. E., Danser, A. H. J., Albert Hofman, D., van Noord, C., Witteman, J. C. M., Uitterlinden, A. G., & Stricker, B. H. C. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833a96d8 · Cited by 17
Messina, A., Puccinelli, E., Gervasi, P. G., & Longo, V. G. (2012) · Research in Veterinary Science · doi:10.1016/j.rvsc.2012.07.015 · Cited by 17
Vascular Hyporeactivity to Angiotensin II and Noradrenaline in a Rabbit Model of Obesity
Jerez, S. J., Scacchi, F., Sierra, L., Karbiner, M. S., & de Bruno, M. P. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318235156a · Cited by 17
Cytochrome P-450 Under Pressure
Fleming, I. (2005) · Circulation · doi:10.1161/01.cir.0000152695.11867.d8 · Cited by 17
Self-citationChadderdon, S. M., Belcik, J. T., Bader, L., Kievit, P., Grove, K. L., & Lindner, J. R. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.117 · Cited by 16
Drug Delivery and Nanoformulations for the Cardiovascular System.
Geldenhuys, W. J., Khayat, M. T. A., Yun, J., & Nayeem, M. A. (2017) · PubMed · Cited by 16
Yi, M., Cho, S., Min, J., Kim, D., Shin, J., & Lee, S. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.03.010 · Cited by 16
Fleming, I. (2003) · Circulation Research · doi:10.1161/01.res.0000095380.06622.d8 · Cited by 16
Self-citationKuczeriszka, M., Olszynski, K. H., Gąsiorowska, A., Sadowski, J., & Kompanowska‐Jezierska, E. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02222.x · Cited by 15
Uehara, S., Uno, Y., Inoue, T., Okamoto, E., Sasaki, E., & Yamazaki, H. (2016) · Xenobiotica · doi:10.3109/00498254.2016.1146366 · Cited by 15
Rahman, A. M., Murrow, J. R., Ozkor, M. A., Kavtaradze, N., Lin, J., Staercke, C. D., Hooper, W. C., Manatunga, A. K., Hayek, S. S., & Quyyumi, A. A. (2014) · Journal of Vascular Research · doi:10.1159/000362666 · Cited by 15
Crossing signals: bioactive lipids in the microvasculature
Chabowski, D. S., Cohen, K. E., Hatoum, O. A., Gutterman, D. D., & Freed, J. K. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00706.2019 · Cited by 16
Morio, Y., Homma, N., Takahashi, H., Yamamoto, A., Nagaoka, T., Sato, K., Muramatsu, M., & Fukuchi, Y. (2007) · Journal of Vascular Research · doi:10.1159/000101778 · Cited by 15
Haschke‐Becher, E., Kirchheiner, J., Trummer, O., Grünbacher, G., Kainz, A., Boehm, B. O., März, W., & Renner, W. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.96 · Cited by 14
Yi, X., Wu, L., Liao, D., Wang, C., & Zhang, B. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.35279 · Cited by 14
Tooker, B. C., Kandel, S. E., Work, H. M., & Lampe, J. N. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101629 · Cited by 14
Krüger‐Genge, A., Köhler, S., Laube, M., Haileka, V., Lemm, S., Majchrzak, K., Kammerer, S., Schulz, C., Storsberg, J., Pietzsch, J., et al. (2023) · Cells · doi:10.3390/cells12151965 · Cited by 14
CytochromeP-450 metabolites in endothelin-stimulated cardiac hormone secretion
Lee, S. J., Landon, C. S., Nazian, S. J., & Dietz, J. R. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00482.2003 · Cited by 14
Kamata, K., Hosokawa, M., Matsumoto, T., & Kobayashi, T. (2006) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.42.171 · Cited by 14
Kowalski, J. A., Swinamer, A. D., Muegge, I., Eldrup, A. B., Kukulka, A. J., Cywin, C. L., & Lombaert, S. D. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.078 · Cited by 14
Rose, R., Banerjee, A., & Ramaiah, S. K. (2006) · Toxicologic Pathology · doi:10.1080/01926230600932497 · Cited by 14
Xu, Y., Henning, R. H., Lipšic, E., van Buiten, A., van Gilst, W. H., & Buikema, H. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.05.003 · Cited by 14
Zhang, M., Shu, H., Chen, C., He, Z., Zhou, Z., & Wang, D. W. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113326 · Cited by 13
Increased Epoxyeicosatrienoic Acid Formation in the Rat Kidney during Liver Cirrhosis
Miyazono, M., Zhu, D., Nemenoff, R. A., Jacobs, E. R., & Carter, E. P. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000076074.63334.99 · Cited by 13
Genetic and Environmental Factors
(2013) · Apple Academic Press eBooks · doi:10.1201/b16340-2 · Cited by 13
Differential expression of cytochrome P450 isoforms in the lungs of septic animals
Cui, X., Wu, R., Zhou, M., Simms, H. H., & Wang, P. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000124877.86743.37 · Cited by 13
Ko, K. M., & Chiu, P. Y. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-4539-1 · Cited by 13
RetractedHizbullah, Ahmed, S., Mumtaz, M. N., Zulfiqar, Z., Hamza, S. A., Siraj, S., Jelani, M., Imran, I., & Khan, A. (2020) · Gene · doi:10.1016/j.gene.2020.144659 · Cited by 12
He, W., Kwesiga, M. P., Gebreyesus, E. A., & Liu, S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82556 · Cited by 13
Vascular biotransformation of organic nitrates is independent of cytochrome P450 monooxygenases
Lopez, M., Malacarne, P. F., Gajos‐Draus, A., Ding, X., Daiber, A., Lundberg, J. O., Offermanns, S., Brandes, R. P., & Rezende, F. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15362 · Cited by 12
Publisher, B. S. P. B. S. (2006) · Current Vascular Pharmacology · doi:10.2174/157016106778521643 · Cited by 12
Parmentier, J., Lavrentyev, E. N., Falck, J. R., Capdevila, J. H., & Malik, K. U. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.03.002 · Cited by 12
Visser, M., Weber, K. L., Rincón, G., & Merritt, D. A. (2017) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12400 · Cited by 13
Chen, H., Kold‐Petersen, H., Laher, I., Simonsen, U., & Aalkjær, C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.09.043 · Cited by 11
Expression of Cytochrome P450‐4A Isoforms in the Rat Cremaster Muscle Microcirculation
Wang, J., Maier, K. G., Roman, R. J., de la Cruz, L., Zhu, J., HENDERSON, L., & Lombard, J. H. (2004) · Microcirculation · doi:10.1080/10739680490266225 · Cited by 11
Jerez, S. J., Sierra, L., & de Bruno, M. P. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.07.008 · Cited by 11
Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.
Ding, Y., Yang, D., Zhou, L., He, P., Yao, J., Xie, P., Lin, D., Sun, D., Sun, P., Li, Q., et al. (2015) · PubMed Central · Cited by 11
The Nicorandil-Induced Vasodilation in Humans Is Inhibited by Miconazole
Ueda, K., Goto, C., Jitsuiki, D., Umemura, T., Nishioka, K., Kimura, M., Noma, K., Nakagawa, K., Oshima, T., Yoshizumi, M., et al. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000155382.06799.20 · Cited by 11
Carnevali, S., Buccellati, C., Bolego, C., Bertinaria, M., Rovati, G. E., & Sala, A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170602083428 · Cited by 10
Navar, L. G., Arendshorst, W. J., Pallone, T. L., Inscho, E. W., Imig, J. D., & Bell, P. D. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020413 · Cited by 10
Chatzipieris, F. P., Petsas, E., Lambrinidis, G., Vassiliou, S., & Chasapis, C. T. (2026) · Life · doi:10.3390/life16010163 · Cited by 10
Fu, Z.-Y., Zhu, Q., Ma, Y., Huang, D., Pan, S., Xie, X., Liu, F., & Cha, E. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-143 · Cited by 9
Özveren, E., Korkmaz, B., Buharalioglu, C. K., & Tunçtan, B. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.05.001 · Cited by 9
Loss of endothelium-dependent relaxation in abdominal aorta preserved in a co-storage system
Knes, J. M., Hansen, T. N., GILLIGAN, B. J., Woo, H., Mangino, M. J., Haworth, R. A., & Southard, J. H. (2004) · Transplant International · doi:10.1007/s00147-004-0788-2 · Cited by 9
Ying, C., Noguchi, T., Aso, H., Ikeda, K., Yamori, Y., & Nara, Y. (2008) · Hypertension Research · doi:10.1291/hypres.31.1821 · Cited by 8
Renal Cortical and Medullary Microcirculations
Pallone, T. L., & Cao, C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00024-0 · Cited by 8
Cytochrome P450 and ischemic heart disease: current concepts and future directions
Rowland, A., & Mangoni, A. A. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.859675 · Cited by 8
P450 in the Angiogenesis Affair
Ljubimov, A. V., & Grant, M. B. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62257-2 · Cited by 8
Biology of Nitric Oxide Synthases
Fleming, I. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020403 · Cited by 7
Self-citationBhatnagar, A. (2004) · Circulation Research · doi:10.1161/01.res.0000142314.55287.a1 · Cited by 8
Redox Regulation of the Microcirculation
Kadlec, A. O., & Gutterman, D. D. (2019) · Comprehensive physiology · doi:10.1002/cphy.c180039 · Cited by 10
Pallone, T. L., Edwards, A., & Mattson, D. L. (2012) · Comprehensive physiology · doi:10.1002/j.2040-4603.2012.tb00396.x · Cited by 7
Miyoshi, T., Naoe, S., Wakabayashi, H., Yano, T., Mori, T., Kanda, S., Arita, M., & Ito, H. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64135 · Cited by 7
Makino, A., Firth, A. L., & Yuan, J. X. ‐. (2011) · Comprehensive physiology · doi:10.1002/j.2040-4603.2011.tb00358.x · Cited by 7
Granville, D. J., & Gottlieb, R. A. (2005) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2005.05.005 · Cited by 7
Dietary Silica Modifies the Characteristics of Endothelial Dilation in Rat Aorta
Öneŕ, G., Cırrık, S., Bülbül, M., & Yuksel, S. (2006) · Endothelium · doi:10.1080/10623320600660045 · Cited by 7
Caron, N., el Hajjam, A., Declèves, A., Joly, E., Falck, J. R., & Kramp, R. A. (2004) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.0305-1870.2004.04066.x · Cited by 7
Endothelial deletion of the cytochrome P450 reductase leads to cardiac remodelling
Lopez, M., Malacarne, P. F., Ramanujam, D. P., Warwick, T., Müller, N., Hu, J., Dewenter, M., Weigert, A., Günther, S., Gilsbach, R., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1056369 · Cited by 6
Mallem, Y., Thuleau, A., Noireaud, J., Desfontis, J., & Gogny, M. (2010) · American Journal of Veterinary Research · doi:10.2460/ajvr.71.7.773 · Cited by 6
Liu, W., Sui, D., Ye, H., Ouyang, Z., & Wei, Y. (2019) · PeerJ · doi:10.7717/peerj.6807 · Cited by 6
Kompanowska‐Jezierska, E., & Kuczeriszka, M. (2008) · PubMed · Cited by 6
Gerová, M., & Kittová, M. (2006) · Physiological Research · doi:10.33549/physiolres.930831 · Cited by 6
Biology of Nitric Oxide Synthases
Fleming, I. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00003-6 · Cited by 6
Self-citationRegulation of Cerebral Blood Flow: Response to Cytochrome P450 Lipid Metabolites
Harder, D. R., Rarick, K. R., Gebremedhin, D., & Cohen, S. S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170025 · Cited by 7
Dannesboe, J., Bastrup, J., Nielsen, K. H., Munck, P., Thomsen, M. B., Hawkins, C. L., & Jepps, T. A. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107540 · Cited by 6
Metadata
- Authors
- Fleming, I.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Fleming, Ingrid
- ORCID
- Fleming, Ingrid
- Venue
- Circulation Research
- Published
- 2001-10-26
- Volume
- 89
- Issue
- 9
- Pages
- 753-762
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2168349092
- Cited by
- 383
- References
- 142
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 3 · 2023: 5 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 13 · 2018: 11 · 2017: 15 · 2016: 11 · 2015: 11 · 2014: 21 · 2013: 8 · 2012: 13
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 553)
- Servier
- Institut de Recherches Servier
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- cytochrome P450, vascular homeostasis, arachidonic acid metabolism, epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, endothelial cells, vascular smooth muscle cells, vasodilation, vasoconstriction, myogenic response, reactive oxygen species, signal transduction, angiogenesis, hypertension, atherosclerosis, cardiovascular disease
- MeSH terms
- Animals, Biological Factors, Cardiovascular System, Cytochrome P-450 Enzyme System, Endothelium, Vascular, Epoxy Compounds, Free Radicals, Homeostasis, Humans, Hydroxyeicosatetraenoic Acids, Mixed Function Oxygenases, Isoenzymes, Muscle, Smooth, Vascular, Vasomotor System, 8,11,14-Eicosatrienoic Acid, Arachidonic Acid, Cytochrome P-450 CYP4A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review